Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 28 studies | 27% ± 10% | |
endothelial cell | 15 studies | 24% ± 9% | |
conventional dendritic cell | 15 studies | 29% ± 14% | |
B cell | 14 studies | 20% ± 4% | |
ciliated cell | 14 studies | 34% ± 16% | |
non-classical monocyte | 14 studies | 26% ± 11% | |
plasmacytoid dendritic cell | 14 studies | 31% ± 12% | |
natural killer cell | 11 studies | 18% ± 2% | |
dendritic cell | 10 studies | 32% ± 20% | |
epithelial cell | 9 studies | 50% ± 24% | |
classical monocyte | 9 studies | 23% ± 10% | |
monocyte | 8 studies | 23% ± 6% | |
myeloid cell | 8 studies | 26% ± 10% | |
oligodendrocyte | 8 studies | 23% ± 7% | |
memory B cell | 8 studies | 18% ± 2% | |
alveolar macrophage | 7 studies | 20% ± 5% | |
type I pneumocyte | 7 studies | 22% ± 8% | |
epithelial cell of proximal tubule | 7 studies | 43% ± 13% | |
enterocyte | 6 studies | 38% ± 11% | |
abnormal cell | 6 studies | 30% ± 14% | |
basal cell | 6 studies | 27% ± 12% | |
microglial cell | 6 studies | 25% ± 7% | |
secretory cell | 5 studies | 26% ± 8% | |
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 20% ± 3% | |
kidney loop of Henle epithelial cell | 5 studies | 30% ± 9% | |
naive B cell | 5 studies | 19% ± 4% | |
astrocyte | 4 studies | 27% ± 12% | |
endothelial cell of artery | 4 studies | 22% ± 4% | |
goblet cell | 4 studies | 22% ± 3% | |
club cell | 3 studies | 26% ± 7% | |
respiratory goblet cell | 3 studies | 38% ± 13% | |
squamous epithelial cell | 3 studies | 39% ± 22% | |
pancreatic A cell | 3 studies | 27% ± 10% | |
mononuclear phagocyte | 3 studies | 30% ± 16% | |
hematopoietic precursor cell | 3 studies | 30% ± 7% | |
plasma cell | 3 studies | 33% ± 10% | |
endothelial cell of vascular tree | 3 studies | 18% ± 2% | |
intermediate monocyte | 3 studies | 29% ± 11% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 4% | |
enteroendocrine cell | 3 studies | 26% ± 3% | |
group 3 innate lymphoid cell | 3 studies | 21% ± 6% | |
brush cell | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 10085.31 | 245 / 245 | 100% | 127.79 | 502 / 502 |
brain | 100% | 8623.43 | 2642 / 2642 | 100% | 63.06 | 703 / 705 |
kidney | 100% | 26165.71 | 89 / 89 | 100% | 252.35 | 898 / 901 |
skin | 100% | 4971.95 | 1808 / 1809 | 99% | 62.92 | 469 / 472 |
breast | 100% | 6894.51 | 459 / 459 | 99% | 65.47 | 1108 / 1118 |
pancreas | 100% | 5614.16 | 328 / 328 | 99% | 49.18 | 176 / 178 |
thymus | 100% | 11535.04 | 653 / 653 | 99% | 76.68 | 597 / 605 |
liver | 100% | 12563.52 | 226 / 226 | 98% | 49.18 | 398 / 406 |
lung | 100% | 9102.99 | 578 / 578 | 98% | 51.44 | 1128 / 1155 |
bladder | 100% | 6311.52 | 21 / 21 | 97% | 53.97 | 488 / 504 |
stomach | 99% | 7370.96 | 357 / 359 | 97% | 41.00 | 278 / 286 |
uterus | 100% | 4118.15 | 170 / 170 | 97% | 50.76 | 443 / 459 |
intestine | 100% | 7567.71 | 963 / 966 | 97% | 47.15 | 510 / 527 |
esophagus | 99% | 4609.25 | 1436 / 1445 | 95% | 33.45 | 173 / 183 |
ovary | 100% | 3772.49 | 180 / 180 | 92% | 33.26 | 396 / 430 |
adrenal gland | 100% | 4197.56 | 258 / 258 | 63% | 15.56 | 145 / 230 |
adipose | 100% | 5766.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 92.04 | 29 / 29 |
spleen | 100% | 13549.23 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.88 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.60 | 1 / 1 |
heart | 98% | 3311.30 | 840 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 2943.24 | 1295 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 47.36 | 76 / 80 |
peripheral blood | 92% | 4921.16 | 853 / 929 | 0% | 0 | 0 / 0 |
muscle | 76% | 1624.85 | 613 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0103046 | Molecular function | alanylglutamate dipeptidase activity |
GO_0070573 | Molecular function | metallodipeptidase activity |
GO_0004180 | Molecular function | carboxypeptidase activity |
GO_0016805 | Molecular function | dipeptidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CNDP2 |
Protein name | Carnosine dipeptidase 2 Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase) Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Threonyl dipeptidase) Alternative protein CNDP2 |
Synonyms | HEL-S-13 CN2 CPGL PEPA |
Description | FUNCTION: Catalyzes the peptide bond hydrolysis in dipeptides, displaying a non-redundant activity toward threonyl dipeptides (By similarity). Mediates threonyl dipeptide catabolism in a tissue-specific way (By similarity). Has high dipeptidase activity toward cysteinylglycine, an intermediate metabolite in glutathione metabolism . Metabolizes N-lactoyl-amino acids, both through hydrolysis to form lactic acid and amino acids, as well as through their formation by reverse proteolysis . Plays a role in the regulation of cell cycle arrest and apoptosis . . |
Accessions | ENST00000582589.5 ENST00000583216.5 J3QKQ0 ENST00000581513.5 ENST00000581912.1 J3KSV5 J3QL02 ENST00000579624.1 ENST00000584768.5 ENST00000579847.5 [Q96KP4-1] J3QQN6 J3QR27 Q96KP4 J3KSS4 ENST00000583203.5 ENST00000584613.5 J3KRD5 J3QRD0 J3QRP4 J3KRJ8 J3QRH4 ENST00000583785.5 A0A087WYZ1 ENST00000577600.5 ENST00000324262.9 [Q96KP4-1] L8EAZ5 J3QLU1 ENST00000581272.5 ENST00000579583.5 ENST00000580672.5 J3QKT2 ENST00000324301.12 [Q96KP4-2] J3QRA8 A0A087WVS2 ENST00000582666.5 ENST00000582260.5 ENST00000577355.2 |